Skip to main content
SpringerLink
Log in

Thrombophilic screening in Turner syndrome

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aim: The aim of this study was to determine, in patients with Turner syndrome (TS), the prevalence of thrombophilic disorders correlating with a higher risk of venous thromboembolism (VTE), to evaluate if thrombophilia is associated with the genetic features of these patients and whether screening before hormone replacement therapy (HRT) is advisable. Patients and methods: We examined 82 TS patients. In all patients we analyzed activated factor VIII:C, fibrinogen, antithrombin (AT), protein C (PC), protein S (PS), activated PC resistance, and homocysteine. For every patient, an investigation for mutations in prothrombin G20210A, factor V R506Q, methylenetetrahydropholate reductase (MTHFR) C 677T and A1298C was conducted. Results: Low values of PC in 3 patients (3.70%), low values of PS in 12 (14.81%), and hyperhomocysteinemia in 4 (4.87%) were found; 52 girls (64.2%) presented hyperfibrinogenemia. Three patients were heterozygous for the prothrombin G20210A allele mutation (3.66%) and the factor V mutation was present in 4 patients (4.88%). No TS patient had a homozygous mutation. Mutations in the MTHFR gene were present in 62 girls, in 17 patients (20.7%) they were homozygous and in 45 patients (54.88%) heterozygous. Conclusions: Considering the increased risks with the association between VTE and the higher prevalence of PC and PS deficiencies, TT genotype mutations and high level of fibrinogen, it is advisable to perform a complete thrombophilia screening in TS patients before starting HRT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lippe B. Primary ovarian failure. In: Kaplan SA ed. Clinical Pediatric Endocrinology. 2nd ed. Philadelphia: WB Saunders Company. 1990, 325–65.

    Google Scholar 

  2. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996, 87: 3531–44.

    PubMed  Google Scholar 

  3. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999, 353: 1167–73.

    Article  CAS  PubMed  Google Scholar 

  4. Vandenbroucke JP, Rosing J, Bloemenkamp KWM, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001, 344: 1527–35.

    Article  CAS  PubMed  Google Scholar 

  5. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965, 13: 516–30.

    CAS  PubMed  Google Scholar 

  6. Griffin J, Evatt B, Zimmerman T, Kleiss A, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981, 68: 1370–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Comp P, Esmon C. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984, 311: 1525–8.

    Article  CAS  PubMed  Google Scholar 

  8. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984, 64: 1297–300.

    CAS  PubMed  Google Scholar 

  9. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993, 342: 1503–6.

    Article  CAS  PubMed  Google Scholar 

  10. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995, 345: 152–5.

    Article  CAS  PubMed  Google Scholar 

  11. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism: results of the Spanish multi center study of thrombofilia. Thromb Haemost 1997, 77: 444–51.

    CAS  PubMed  Google Scholar 

  12. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001, 344: 1222–31.

    Article  CAS  PubMed  Google Scholar 

  13. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994, 330: 517–22.

    Article  CAS  PubMed  Google Scholar 

  14. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a co-factor to activated protein C. Proc Natl Acad Sci U S A 1993, 90: 1004–8.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88: 3698–703.

    CAS  PubMed  Google Scholar 

  16. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369: 64–7.

    Article  CAS  PubMed  Google Scholar 

  17. Zivelin A, Rosemberg N, Faier S, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998, 92: 1119–24.

    CAS  PubMed  Google Scholar 

  18. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Sem Thromb Haemost 1998, 24: 367–79.

    Article  Google Scholar 

  19. De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G. Interaction between hyperhomocisteinemia and inherited thrombophilic factors in venous thromboembolism. Semin Thromb Hemost 2000, 26: 305–11.

    Article  PubMed  Google Scholar 

  20. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ. Hyperhomocisteinemia and venous thrombosis: a meta analysis. Thromb Haemost 1998, 80: 874–7.

    Google Scholar 

  21. Cattaneo M. Hyperhomocisteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999, 81: 165–76.

    CAS  PubMed  Google Scholar 

  22. Pabinger I, Schneider B. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein-S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors. Thromb Haemost 1994, 71: 548–52.

    CAS  PubMed  Google Scholar 

  23. Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci PM. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscl Thromb Vasc Biol 1999, 19: 700–3.

    Article  CAS  PubMed  Google Scholar 

  24. Spannagl M, Heinemann LA, Schramm W. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism? Eur J Contracept Reprod Health Care 2000, 5: 105–12.

    Article  CAS  PubMed  Google Scholar 

  25. Emmerich J, Rosendaal FR, Cattaneo M, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism: pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost 2001, 86: 809–16.

    CAS  PubMed  Google Scholar 

  26. Rosendaal Fr, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001, 116: 112–23.

    Google Scholar 

  27. Bath LE, Critchley HO, Kelnar CJ, Wallace WH. Choice of hormone replacement therapy in young women with ovarian failure. Clin Endocrinol 2001, 55: 697–8.

    Article  CAS  Google Scholar 

  28. Elsheikh M, Hodgson HJ, Wass JA, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner’s syndrome. Clin Endocrinol 2002, 56: 359–65.

    Article  Google Scholar 

  29. Larizza D, Locatelli M, Vitali L, et al. Serum liver enzymes in Turner syndrome. Eur J Pediatr 2000, 159: 143–8.

    Article  CAS  PubMed  Google Scholar 

  30. El-Mansoury M, Berntorp K, Bryman I, et al. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin Endocrinol (Oxf) 2008, 68: 485–90.

    Article  CAS  Google Scholar 

  31. Høst C, Christiansen JJ, Christiansen JS, Jorgensen JO, Gravholt CH. Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes. Growth Horm IGF Res 2010, 20: 26–30.

    Article  PubMed  Google Scholar 

  32. Koulouri O, Ostberg J, Conway GS. Liver dysfunction in Turner’s syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin Endocrinol 2008, 69: 306–10.

    Article  CAS  Google Scholar 

  33. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994, 87: 106–12.

    Article  CAS  PubMed  Google Scholar 

  34. Rees DC. The population genetics of factor V Leiden (arg506Gln). Br J Haematol 1996, 95: 579–86.

    Article  CAS  PubMed  Google Scholar 

  35. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphism-the Leiden Thrombophilia Studt (LETS). Thromb Haemost 1994, 71: 719–22.

    CAS  PubMed  Google Scholar 

  36. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000, 95: 3678–82.

    PubMed  Google Scholar 

  37. Meijers JC, Tekelenburg WL, Bouma BN, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000, 342: 696–701.

    Article  CAS  PubMed  Google Scholar 

  38. von Depka M, Nowak-Göttl U, Eisert R, et al. Increased lipopro-tein(a) levels as an independent risk factor for venous thromboembolism. Blood 2000, 96: 3364–8.

    Google Scholar 

  39. Georgiadou P, Sbarouni E. Effect of hormone replacement therapy on inflammatory biomarkers. Adv Clin Chem 2009, 47: 59–93.

    Article  CAS  PubMed  Google Scholar 

  40. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting factors. Arch Intern Med 2000, 160: 49–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, IRCCS Policlinico S. Matteo Foundation, P.le Golgi n.2, 27100, Pavia, Italy

    V. Calcaterra, G. Lanati & D. Larizza

  2. Department of Internal Medicine, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

    G. Gamba & N. Montani

  3. Biometric Unit, Scientific Direction, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

    A. de Silvestri

  4. S.C. Medicine of Laboratory Virology and Microbiology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

    V. Terulla

Authors
  1. V. Calcaterra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Gamba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Montani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. de Silvestri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Terulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Lanati
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Larizza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Calcaterra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calcaterra, V., Gamba, G., Montani, N. et al. Thrombophilic screening in Turner syndrome. J Endocrinol Invest 34, 676–679 (2011). https://doi.org/10.3275/7724

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/7724

Key-words

Search

Navigation